within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M05B_DrugsAffectingBoneStructureAndMineralization.M05BX08_Menatetrenone;

model Menatetrenone
  extends Pharmacolibrary.Drugs.ATC.M.M05BX08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M05BX08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Menatetrenone (vitamin K2, MK-4) is a synthetic form of vitamin K2 used mainly in the treatment and prevention of osteoporosis, particularly in postmenopausal women and elderly patients. It is approved for use in Japan for bone health but is not widely approved in other countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic model parameters in healthy adult population, as referenced publications with detailed PK modeling were not available for menatetrenone.</p><h4>References</h4><ol><li><p>Uematsu, T, et al., &amp; Kanamaru, M (1996). Effect of dietary fat content on oral bioavailability of menatetrenone in humans. <i>Journal of pharmaceutical sciences</i> 85(9) 1012–1016. DOI:<a href=\"https://doi.org/10.1021/js9600641\">10.1021/js9600641</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8877895/\">https://pubmed.ncbi.nlm.nih.gov/8877895</a></p></li><li><p>Sugimoto, T, et al., &amp; Tagawa, H (2002). Pharmacodynamics of menatetrenone and effects on bone metabolism in continuous ambulatory peritoneal dialysis patients. <i>The Journal of international medical research</i> 30(6) 566–575. DOI:<a href=\"https://doi.org/10.1177/147323000203000604\">10.1177/147323000203000604</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12526283/\">https://pubmed.ncbi.nlm.nih.gov/12526283</a></p></li><li><p>Okano, T, et al., &amp; Kamao, M (2009). [In vivo metabolism of vitamin K: in relation to the conversion of vitamin K1 to MK-4]. <i>Clinical calcium</i> 19(12) 1779–1787. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19949269/\">https://pubmed.ncbi.nlm.nih.gov/19949269</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Menatetrenone;
